Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy

NCT06989541 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hypogammaglobulinemia, Acquired

Interventions

BIOLOGICAL: Immune Globulin Intravenous (Human), 10%
BIOLOGICAL: Immune Globulin Subcutaneous (Human), 20% Solution

Sponsor

University of Alberta